Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer Pirus GhadjarDaniel M. AebersoldProstate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and The Working Party Radiation Oncology of the German Cancer Society (DKG-ARO) Review Article Open access 12 March 2020 Pages: 589 - 597
Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities Stratos VassisBeatrice NöldekeRoland Merten Original Article Open access 10 February 2020 Pages: 598 - 607
Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer Ciro FranzeseMarco BadalamentiMarta Scorsetti Original Article 17 April 2020 Pages: 608 - 616
Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer+ Franco CampostriniAndrea RemoGiuseppe Verlato Original Article 12 March 2020 Pages: 617 - 627
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer Francesco CucciaLuca NicosiaFilippo Alongi Original Article 12 May 2020 Pages: 628 - 636
PSMA-positive nodal recurrence in prostate cancer Nina-Sophie Schmidt-HegemannAlexander BuchnerAlexander Kretschmer Original Article Open access 24 March 2020 Pages: 637 - 646
Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients Felix BöckelmannFlorian PutzChristoph Bert Original Article Open access 10 March 2020 Pages: 647 - 656
Duration-dependent margins for prostate radiotherapy—a practical motion mitigation strategy Eric Pei Ping PangKellie KnightJeffrey Kit Loong Tuan Original Article 13 January 2020 Pages: 657 - 663
An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report Alexander D. SherryMichael BezzeridesAustin N. Kirschner Case Study 31 January 2020 Pages: 664 - 670
Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom: Langzeitergebnisse der ABCSG-8A-Studie David KrugMarciana-Nona Duma Literatur kommentiert Open access 16 April 2020 Pages: 671 - 673
Intensitätsmodulierte fraktionierte Radiotherapie vs. körperstereotaktische Radiotherapie des Prostatakarzinoms (PACE-B) – akute Toxizität aus einer internationalen, randomisierten Phase-III-Nichtunterlegenheitsstudie Gerhard G. Grabenbauer Literatur kommentiert 22 April 2020 Pages: 674 - 675
Zirkulierende HPV-Tumor-DNA als möglicher Biomarker in der Rezidivdiagnostik des HPV-assoziierten Oropharynxkarzinoms Alexander RühleNils H. Nicolay Literatur kommentiert Open access 15 April 2020 Pages: 676 - 678